MedPath

Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial

Completed
Conditions
Clinical Trial
Supportive Care
Metastatic Cancer
Registration Number
NCT04896099
Lead Sponsor
Institut Curie
Brief Summary

The purpose of the study is to assess the supportive care needs of patients enrolled in a therapeutic trial for metastatic cancer.

Detailed Description

All patients included in a therapeutic trial will be offered an analysis of their supportive care needs from the following options:

* dietetics

* psychological

* pain management

* Palliative medicine consultation or day hospital

* onco-geriatrics

* social assistance

* Physiotherapist care If an intervention(s) is selected, it will be offered in addition to the patient's participation in the therapeutic trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • metastatic cancer
  • patient included in a clinical trial
Exclusion Criteria
  • patient deprived of his freedom

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EORTC Core Quality of Life Questionnaire (EORTC QLQ-C30)3 months

Descritive results with validated questionnaire for the assessment of Quality of life in patient with cancer. 30 Questions

National Comprehensive Cancer Network (NCCN) Distress thermometer3 months

Descritive results with validated questionnaire for distress assessment (scale from 0 to 10 and list of problems to be ticked by the patient

Questionnaire G8 oncodage3 months

Descritive results with validated questionnaire for the identification of geriatric frailties in 70 year old cancer patients. Score on 17 points: \> 14 = standard care, \<14 = specialized geriatric evaluation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Curie

🇫🇷

Paris, France

Institut Curie
🇫🇷Paris, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.